Skip to main content
. 2021 Jul 27;13(8):2570. doi: 10.3390/nu13082570

Figure 1.

Figure 1

Body (A) and uterine (B) weights in mice that were sham operated or ovariectomized and untreated or administered EV, LVK, or HVK for 12 weeks. Values are mean ± SD, n = 8–10 per treatment. Labeled without a common letter means a significant difference, p < 0.05. EV, estradiol valerate; HVK; MK-4 40 mg/kg body weight group; LVK, MK-4 20 mg/kg body weight group; MK-4, menaquinone-4; OVX, ovariectomized group; SD, standard deviation.